Core Scientific, Inc. Common Stock
CORZ
CORZ was delisted on the 30th of December, 2022.
91 hedge funds and large institutions have $210M invested in Core Scientific, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 56 funds opening new positions, 19 increasing their positions, 8 reducing their positions, and 35 closing their positions.
164% more call options, than puts
Call options by funds: $41.5M | Put options by funds: $15.7M
138% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 8
60% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 35
28% more funds holding
Funds holding: 71 → 91 (+20)
19% more capital invested
Capital invested by funds: $175M → $210M (+$34.1M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$27.2M |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$20.4M |
| 3 |
PWM
Perigon Wealth Management
San Francisco,
California
|
+$15.6M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$11.5M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$10.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$24.2M |
| 2 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$10.2M |
| 3 |
ACA
Arena Capital Advisors
Los Angeles,
California
|
-$10M |
| 4 |
Nomura Holdings
Tokyo,
Japan
|
-$7.26M |
| 5 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
-$6.15M |
CORZ Hedge Fund Activity: Q1 2022 in Review
91 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Core Scientific, Inc. Common Stock (CORZ) for Q1 2022, worth a combined $210M — up 19% from $175M a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new CORZ positions and 35 closed out — a net gain of 21 holders — while 19 added to existing stakes and 8 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $27.2M. The largest seller was Rubric Capital Management (New York), exiting entirely with an estimated $24.2M sold.
- 91 institutional investors held Core Scientific, Inc. Common Stock (CORZ) as of Q1 2022, up from 71 in Q4 2021.
- Funds reported $210M of Core Scientific, Inc. Common Stock stock for Q1 2022, up 19% quarter-over-quarter.
- 56 funds opened new Core Scientific, Inc. Common Stock positions in Q1 2022 and 35 closed out, a net change of +21 holders.
- The largest Core Scientific, Inc. Common Stock buyer in Q1 2022 was Vanguard Group, an estimated $27.2M added.
- The largest Core Scientific, Inc. Common Stock seller in Q1 2022 was Rubric Capital Management (New York), an estimated $24.2M sold.
Based on aggregated 13F filings for Q1 2022.